In a striking, unexpected discovery, researchers at Albert Einstein College of Medicine of Yeshiva University have determined that vitamin C kills drug-resistant tuberculosis (TB) bacteria in laboratory culture.
The finding suggests that vitamin C added to existing TB drugs could shorten TB therapy, and it highlights a new area for drug design. The study was published today in the online journal Nature Communications.
TB is caused by infection with the bacterium M. tuberculosis. In 2011, TB sickened some 8.7 million people and took some 1.4 million lives, according to the World Health Organization. Infections that fail to respond to TB drugs are a growing problem: About 650,000 people worldwide now have multi-drug-resistant TB (MDR-TB), 9 percent of whom have extensively drug-resistant TB (XDR-TB).TB is especially acute in low and middle income countries, which account for more than 95 percent of TB-related deaths, according to the World Health Organization.
The Einstein discovery arose during research into how TB bacteria become resistant to isoniazid, a potent first-line TB drug. The lead investigator and senior author of the study was William Jacobs, Jr., Ph.D., professor of microbiology & immunology and of genetics at Einstein. Dr. Jacobs is a Howard Hughes Medical Institute investigator and a recently elected member of the National Academy of Sciences.
Dr. Jacobs and his colleagues observed that isoniazid-resistant TB bacteria were deficient in a molecule called mycothiol. “We hypothesized that TB bacteria that can’t make mycothiol might contain more cysteine, an amino acid,” said Dr. Jacobs. “So, we predicted that if we added isoniazid and cysteine to isoniazid-sensitive M. tuberculosis in culture, the bacteria would develop resistance. Instead, we ended up killing off the culture— something totally unexpected.”
The Einstein team suspected that cysteine was helping to kill TB bacteria by acting as a “reducing agent” that triggers the production of reactive oxygen species (sometimes called free radicals), which can damage DNA.
“To test this hypothesis, we repeated the experiment using isoniazid and a different reducing agent— vitamin C,” said Dr. Jacobs. “The combination of isoniazid and vitamin C sterilized the M. tuberculosis culture. We were then amazed to discover that vitamin C by itself not only sterilized the drug-susceptible TB, but also sterilized MDR-TB and XDR-TB strains.”
To justify testing vitamin C in a clinical trial, Dr. Jacobs needed to find the molecular mechanism by which vitamin C exerted its lethal effect. More research produced the answer: Vitamin C induced what is known as a Fenton reaction, causing iron to react with other molecules to create reactive oxygen species that kill the TB bacteria.
“We don’t know whether vitamin C will work in humans, but we now have a rational basis for doing a clinical trial,” said Dr. Jacobs. “It also helps that we know vitamin C is inexpensive, widely available and very safe to use. At the very least, this work shows us a new mechanism that we can exploit to attack TB.”
The Latest Bing News on:
Drug-Resistant TB
- Experts developing immune-enhancing therapies to treat TB: Studyon April 28, 2024 at 9:33 am
Experts are developing revolutionary immune-enhancing medicines known as host-directed therapies, which employ the body's immune system to target TB, to tackle even drug-resistant strains of the ...
- Enhancing Immunity to Combat Tuberculosison April 27, 2024 at 9:10 am
Researchers explore host-directed therapies, harnessing the body's immune system to combat tuberculosis, including drug-resistant strains.
- Experts develop immune-enhancing therapies to target tuberculosison April 26, 2024 at 3:13 pm
Experts are working on novel immune-enhancing therapies called host-directed therapies to use the body's own immune system to target tuberculosis, with hopes that they could tackle even the ...
- Africa: TB Clinical Trials: An UnPrecedented €34 Million Price Tag in Drug Developmenton April 26, 2024 at 11:10 am
Press Release - At the 5th WHO Pharmaceutical Pricing and Reimbursement Policies conference today, Doctors Without Borders (MSF) presented the costs of its landmark TB-PRACTECAL clinical trial that ...
- Drug-resistant tuberculosis responds rapidly to bedaquiline-based second-line therapy, claims studyon April 25, 2024 at 8:31 am
Patients who have drug-resistant tuberculosis (TB) have a similar microbiological response to bedaquiline-based second-line medications as patients with drug-sensitive TB taking ...
- In first such test, bedaquiline cures 4 kids of drug-resistant TBon April 21, 2024 at 7:51 pm
Bedaquiline treatment at JJ Hospital shows promise in treating pre-XDR-TB in children under five. The drug's success in younger patients may lead to b ...
- Lack of drug-susceptibility data for TB can compromise treatment outcomes: studyon April 17, 2024 at 7:01 pm
The study is based on real-world data on the TB drug-resistance profile by whole genome sequencing (WGS) of 600 clinical samples from patients with TB in India.
- Whole genome sequencing could be key to detecting drug-resistant TB, shows studyon April 17, 2024 at 5:33 am
India faces challenges because of low investment in public health programs, high endemicity in difficult-to-reach locations, and persisting diagnostic gaps.
- Significant challenge posed by drug-resistant TB strains to efficacy of treatment, control measures: Studyon April 17, 2024 at 1:44 am
The findings highlighted resistance not only to rifampicin, a drug used to manage and treat diverse mycobacterial infections, and isoniazid, an antibiotic indicated in the first-line treatment of ...
- Absence of full drug-susceptibility data for TB patients can result in amplifying resistance: studyon April 16, 2024 at 7:48 pm
Study by HaystackAnalytics & Dr. D.Y. Patil Medical College reveals high prevalence of pre-XDR-TB in MDR-TB cases in India.
The Latest Google Headlines on:
Drug-Resistant TB
[google_news title=”” keyword=”Drug-Resistant TB” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
The Latest Bing News on:
Tuberculosis
- The path to a better tuberculosis vaccine runs through Montanaon April 29, 2024 at 10:20 am
A team of Montana researchers is playing a key role in the development of a more effective vaccine against tuberculosis, an infectious disease that has killed more people than any other.
- Tuberculosis case in Corby school as health bosses begin screening 'close contacts'on April 29, 2024 at 7:36 am
A child at Brooke Weston Academy in Corby has received a diagnosis of tuberculosis. The illness is rarely seen in children in the UK and causes a persistent cough, a high temperature, weight loss, ...
- After steady decline, TB has increased every year since 2020 in U.S.on April 29, 2024 at 2:30 am
But the CDC report describes the incidence of TB in the United States as still “among the lowest in the world.” ...
- Harnessing immune enhancement to combat drug-resistant tuberculosison April 28, 2024 at 11:17 am
Experts are working on novel immune-enhancing therapies called host-directed therapies to use the body's own immune system to target tuberculosis, with hopes that they could tackle even the ...
- Enhancing Immunity to Combat Tuberculosison April 27, 2024 at 9:10 am
Researchers explore host-directed therapies, harnessing the body's immune system to combat tuberculosis, including drug-resistant strains.
- Experts develop immune-enhancing therapies to target tuberculosison April 26, 2024 at 3:10 pm
Experts are working on novel immune-enhancing therapies called host-directed therapies to use the body's own immune system to target tuberculosis, with hopes that they could tackle even the ...
- Revvity unveils a new era of automated tuberculosis testingon April 26, 2024 at 8:38 am
Revvity, Inc. (NYSE: RVTY) today announced the launch of the Auto-Pure 2400 liquid handler from Allsheng for use with the T-SPOT.TB test. The Auto-Pure 2400 platform is easy to use and designed to ...
- A new hope for tuberculosis?on April 26, 2024 at 6:13 am
If we can say “COVID is still here,” then what of tuberculosis (TB), which has been around since time immemorial and has killed more Filipinos than the coronavirus, even during the ...
- She Died Of Tuberculosis During The New England Vampire Panic, But Her Family Believed She Was Haunting Her Sister, So They Dug Up Her Grave, Removed Her Heart, And Burned It ...on April 25, 2024 at 4:00 pm
At one point in time, Rhode Island was consumed with what we call a vampire panic today. Due to an outbreak of tuberculosis and the freaky symptoms the disease caused, many people believed that the ...
- Drug-resistant tuberculosis responds rapidly to bedaquiline-based second-line therapy, claims studyon April 25, 2024 at 8:31 am
Patients who have drug-resistant tuberculosis (TB) have a similar microbiological response to bedaquiline-based second-line medications as patients with drug-sensitive TB taking ...
The Latest Google Headlines on:
Tuberculosis
[google_news title=”” keyword=”tuberculosis” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]